:: Publications   :: Talks   :: Industry Strategy Maps   :: Contact

Publications

:: Other People's Patents: Using Information for Innovations
Patent data can provide a low cost boost to your innovation program. IP legal experts show you how to reap the benefits and avoid the pitfalls.   


 

:: Network Patent Analysis (NPA) to support IP Strategy
Spielthenner and Lloyd explain how patent citation data can be used to cluster and rank patents for the benefit of IP managers, R&D managers, IP investors and patent litigators.   


:: Stem cell patents: a landscape analysis
An evaluation of the development of innovation in stem cell technologies by network analysis of stem cell patent filings. For a copy of the article please contact us directly.   


:: Use Your Influencer    
It is clear that physician influence is declining, that the legacy model doesn't offer a competitive advantage, and that a new model is needed. An integrated approach to the identification and evaluation of key opinion leaders and decision makers can optimize your marketing strategy, says Doris Spielthenner  


:: Taking Back Control                                                                                                                Individual perceptions, word-of-mouth and the media create new meanings and sometimes mutilate the hard work of the brand marketer.


:: Key Opinion Leader (KOL) Mapping: Breast Cancer - USA Landscape Analysis,                               Special Focus on KOLs of Tomorrow

Pharma’s appetite for KOLs is growing, argues Doris Spielthenner. This report provides the names and affiliated institutions of the most influential Key Opinion Leaders in the US Breast Cancer Market and shows how they are connected and influence each other. Using sophisticated algorithms the report shows who will be the KOLs of tomorrow and who’s influence is on decline. The report uses rankings, MD segmentation and detailed network visualizations to support Pharma Executives in their KOL Management and Prioritization decisions.

a FAS.research market report; July 2008; By Doris Spielthenner; for a detailed fact sheet and pricing information please send an email or contact FAS directly


:: New Possibilities in Mobilizing Political Influencers

Messaging must take into account not only the opinion of the targeted individual, but also the opinion of the people who surround the influencer - especially the degree of consensus or dissent over a particular issue, say Spielthenner, Gorenflo and Katzmair. Using questionnaires completed by almost 10,000 registered voters, Poli-fluentials: The New Political Kingmakers sheds new light on the American adults who will play – and, indeed, are already playing – an outsized role in the upcoming campaigns.

in Poli-fluentials: The New Political Kingmakers, Chapter 6: IPDI; Oct 4th, 2007; By Doris Spielthenner, Neal Gorenflo, Harald Katzmair


:: Toward a New Paradigm: Understanding Political Influencers

Politicians understand the importance of attracting the support of opinion leaders who are able to influence and mobilize large numbers of other people. Spielthenner and Katzmair explain how to identify and use such "hubs" for grassroots as well as "grasstops" campaigning. 

in Poli-fluentials: The New Political Kingmakers, Chapter 5: IPDI; Oct 4th, 2007; By Doris Spielthenner, Neal Gorenflo, Harald Katzmair

:: Mapping Influence and Interaction - Social Network Analysis for Mobile and Telecom                      The wireless industry is overdue for new models that reveal marketplace realities more accurately, and produce more effective strategies. Spielthenner and Katzmair demonstrate how Social Network Analysis has increasingly provided this new solution, by showing that the market for a wireless carrier is a network in which customers and non‐customers are connected and influence each other. These relationships can be mapped, thereby revealing roles people play within that market — whether they're vulnerable to churn, an ideal change agent, or an ideal spreader or hub for up-selling and cross-selling opportunities within their community of friends, family and co‐workers. 

;                         ::please send an email to obtain a copy of the whitepaper or contact FAS directly.


:: Mapping Influence and Interaction - Social Network Analysis for the Health Care Industry               Today's fast‐moving and interconnected pharmaceutical market demands new strategies. Legacy marketing models have become obsolete, as rising development costs and intensifying competition
are compounded by changes in the healthcare industry. A single‐minded focus on prescriber detailing and old‐fashioned Key Opinion Leader (KOL) strategies can no longer be counted on to drive sales growth say Spielthenner and Katzmair.

                        ::please send an email to obtain a copy of the whitepaper or contact FAS directly.


:: Mapping Influence and Interaction - Social Network Analysis for the Key Account Management 
Today’s marketing applications show how Key Account Managers (KAMs) are connected to existing prospects. But they don’t give an overview of how these prospects are connected to each other and other players in the market argue Spielthenner and Katzmair. The great strength of social network analysis is its capacity to literally map and measure human relationships, which can then be navigated and leveraged for various strategic purposes.

                        ::please send an email to obtain a copy of the whitepaper or contact FAS directly.


:: Good Networks, Bad Networks. A Manual for Decision Makers
This report supports decision makers in the field of economic development to identify and create mileus in which innovation, production and diffusion of innovation can prosper.


:: Ottimizzare gli investimenti nelle relazione con gli stakeholder per mezzo della Social Network          Analysis
Investments into stakeholder relations can be optimized by means of Social Network Analysis argues Doris Spielthenner.

; by Doris Spielthenner


:: Optimizing Key Account Management - From Contacts to Contracts
This business case has been taught at INSEAD to pharmaceutical executives since 2005


:: Strategic Lobbying in Health Care - Optimizing Investments into Stakeholder Relations
This business case has been taught at INSEAD to pharmaceutical executives since 2005


:: Co-Publishing Analysis for Marketing Purposes
This business case has been taught at INSEAD to pharmaceutical executives since 2005